SCHEMBL16277000

SCHEMBL16277000

CO[C@@H]1[C@H](O)[C@H](OCCc2ccc(O)c(O)c2)O[C@@H](COC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCA P17252 7/20 0.82
▸ CYP19A1 P11511 3/20 0.82
▸ MMP2 P08253 1/20 0.78
▸ MMP3 P08254 1/20 0.78
▸ MMP9 P14780 1/20 0.78
▸ MMP12 P39900 1/20 0.78
▸ MMP13 P45452 1/20 0.78
▸ KDM1A O60341 2/20 0.64
▸ L3MBTL1 Q9Y468 2/20 0.60
▸ BACE1 P56817 1/20 0.60
▸ ALDH1A1 P00352 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ ALOX15 P16050 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ HSD17B10 Q99714 1/20 0.59
▸ APP P05067 2/20 0.56
▸ TRPV3 Q8NET8 1/20 0.53
▸ MET P08581 1/20 0.52
▸ BCHE P06276 1/20 0.52
▸ CCNA2 P20248 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16276035 0.96 PRKCA (0.75) PRKCACYP19A1MMP2MMP3MMP9
SCHEMBL17614820 0.95 PRKCA (0.74) PRKCACYP19A1MMP2MMP3MMP9
Calceolarioside B SCHEMBL30913582 0.90 PRKCA (1.00) PRKCACYP19A1MMP2MMP3MMP9
Calceolarioside B SCHEMBL17173771 0.90 PRKCA (1.00) PRKCACYP19A1MMP2MMP3MMP9
Calceolarioside B SCHEMBL29785210 0.90 PRKCA (1.00) PRKCACYP19A1MMP2MMP3MMP9
Calceolarioside B SCHEMBL27983548 0.90 PRKCA (1.00) PRKCACYP19A1MMP2MMP3MMP9
Isoacteoside SCHEMBL16689428 0.88 MMP2 (1.00) PRKCACYP19A1MMP2MMP3MMP9
Isoacteoside SCHEMBL19429735 0.88 MMP2 (1.00) PRKCACYP19A1MMP2MMP3MMP9
Isoacteoside SCHEMBL19429736 0.88 MMP2 (1.00) PRKCACYP19A1MMP2MMP3MMP9
Isoacteoside SCHEMBL29372645 0.88 MMP2 (1.00) PRKCACYP19A1MMP2MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160082064-A1 METHOD FOR REGULATING BLOOD GLUCOSE LEVEL SINPHAR PHARMACEUTICAL CO., LTD. (TW) 2016-03-24 — — US disclosed
US-20140357581-A1 METHOD FOR REGULATING BLOOD GLUCOSE LEVEL SINPHAR PHARMACEUTICAL CO., LTD. (TW) 2014-12-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160082064-A1 METHOD FOR REGULATING BLOOD GLUCOSE LEVEL SIRT1, HDAC3, GCKR PRKCA 659/4885CYP19A1 1085/4885MMP2 1830/4885
US-20140357581-A1 METHOD FOR REGULATING BLOOD GLUCOSE LEVEL SIRT1, HDAC3, GCKR PRKCA 659/4885CYP19A1 1085/4885MMP2 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback